Recruiting NA Hypospadias

New treatment option for Hypospadias

Official title Is Dorsal Inlay Graft (DIG) With TIP Repair Superior to TIP Alone for Primary Hypospadias?

ClinicalTrials.gov ID: NCT07086963

What this study is testing

What it's testing
This prospective, randomized study included all patients who presented with primary hypospadias without chordee, Patients were randomized into two groups as group 1 or group 2,Group 1: Repaired with standard TIP repair as described by Snodgrass Group 2: Repaired with TIP with GIP using preputial graft. In both groups the functional outcomes were primarily compared regarding meatal position, shape, and the functional outcomes of the neourethra, in addition to other complications such as UCF, wound complications, cosmetic results and the need for a second surgery.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 6 to 120, men only

You may be able to join if

  • Primary hypospadias candidates for one-stage repair
  • Uncircumcised cases
  • Pediatric age group
  • Patients with regular follow up

You likely can't join if

  • The presence of chordee or urethral anomalies requiring division of the urethral plate or staged repair
  • Small glans \< 11mm
  • glanular hypospadias

The study team makes the final eligibility decision.

Where it's taking place

  • Cairo, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling male, 6 months to 120 months. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.